Gland Pharma Limited
Gland Pharma Limited scores highest on Nitro (98) and lowest on Price (46). Its PosiPenta is 65.08 out of 100, better than most similar companies.
On the Penta Grid this week, Gland Pharma Limited is Grid #11 of 168 in the Healthcare sector in India, and Grid #147 of 2,356 in India.
Compared with similar companies in the Healthcare sector in India.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Gland Pharma Limited | 65.08 | 46 | 60 | 98 | 60 | 61 |
| Anthem Biosciences Limited | 55.68 | 11 | 47 | 63 | 82 | 76 |
| Ipca Laboratories Limited | 63.54 | 46 | 55 | 84 | 65 | 69 |
| Biocon Limited | 41.66 | 50 | 57 | 27 | 18 | 57 |
| Ajanta Pharma Limited | 65.67 | 35 | 56 | 75 | 80 | 82 |
| Abbott India Limited | 62.61 | 36 | 54 | 43 | 86 | 94 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 44.45 |
| P/B ratio | 4.85 |
EEarnings
| Trailing EPS | ₹68.47 |
| Forward EPS | ₹96.33 |
NNitro
| Price | 3043.40 |
| 52-week high | 3171.00 |
| 52-week low | 1573.60 |
| Fall from 52-week high | 4.0% |
TTorque
| Return on equity (ROE) (calculated) | 10.91% |
| Debt-to-equity | 0.03 |
AAnchor
| Beta (price swings) | 0.58 |
| Market cap | ₹50,219 Cr |
| Promoter holding | 51.77% |
| Dividend yield | 0.65% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Gland Pharma Limited's PosiPenta score?
Gland Pharma Limited's PosiPenta is 65.08 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Gland Pharma Limited stand on the Penta Grid?
On the Penta Grid this week, Gland Pharma Limited is Grid #11 of 168 in the Healthcare sector in India, and Grid #147 of 2,356 in India.
Which PosiPenta pillar is strongest for Gland Pharma Limited?
Nitro (momentum), with a score of 98 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Gland Pharma Limited?
Price (valuation), with a score of 46 out of 100: around the middle of similar companies.
Has Gland Pharma Limited's PosiPenta changed since last week?
Yes, it fell 0.59 points, from 65.67 to 65.08.
PositoAI is for research and education only and is not investment advice.